Literature DB >> 26084635

Opioid risk assessment in palliative medicine.

Daniel Krashin1, Natalia Murinova, Patricia Jumelle, Jane Ballantyne.   

Abstract

INTRODUCTION: Pain management with opioids is a fundamental element of palliative medicine. Since the risks of chronic opioid therapy have emerged, a reassessment of these risks in the setting of palliative care is warranted. AREAS COVERED: This article presents information about opioid-related risks including i) sedation, cognitive impairment and falls; ii) constipation; iii) addiction to opioids and associated aberrant behavior; and iv) death due to respiratory depression. For this article, the medical literature was searched using PubMed and Web of Science for appropriate terms including 'palliative care' and 'opioid risk.' Medical subject headings were used to identify suitable articles including 'Analgesics, Opioid', 'Pain/drug therapy,' 'Palliative Care' and 'Hospice Care.' Further sources were identified by following cross-references within the literature and with the help of the University of Washington library staff. EXPERT OPINION: Palliation of severe pain at the end of life is probably the most widely accepted indication for chronic opioid therapy. At increased doses, adverse effects of opioids may limit or interfere with the benefits of treatment. Careful screening and follow-up will allow risk factors to be recognized and addressed when possible. The use of adjunctive treatments for pain may reduce opioid requirements and yield better outcomes.

Entities:  

Keywords:  addiction; cancer pain; constipation; hospice; injury; opioid use disorder; opioids; palliative care; sedation

Mesh:

Substances:

Year:  2015        PMID: 26084635     DOI: 10.1517/14740338.2015.1041915

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  6 in total

1.  Adjuvant Use and the Intensification of Pharmacologic Management for Pain in Nursing Home Residents with Cancer: Data from a US National Database.

Authors:  Shao-Hsien Liu; Jacob N Hunnicutt; Christine M Ulbricht; Catherine E Dubé; Anne L Hume; Kate L Lapane
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

Review 2.  Opioid Management in Older Adults with Chronic Kidney Disease: A Review.

Authors:  Montgomery T Owsiany; Chelsea E Hawley; Laura K Triantafylidis; Julie M Paik
Journal:  Am J Med       Date:  2019-07-08       Impact factor: 4.965

3.  Behavioral pharmacology of the mixed-action delta-selective opioid receptor agonist BBI-11008: studies on acute, inflammatory and neuropathic pain, respiration, and drug self-administration.

Authors:  Glenn W Stevenson; Denise Giuvelis; James Cormier; Katherine Cone; Phillip Atherton; Rebecca Krivitsky; Emily Warner; Brooke St Laurent; Julio Dutra; Jean M Bidlack; Lajos Szabò; Robin Polt; Edward J Bilsky
Journal:  Psychopharmacology (Berl)       Date:  2020-01-07       Impact factor: 4.530

4.  Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?

Authors:  Lydia J Finney
Journal:  Breathe (Sheff)       Date:  2019-06

5.  "No thanks, I don't want to see snakes again": a qualitative study of pain management versus preservation of cognition in palliative care patients.

Authors:  Pete Wegier; Jaymie Varenbut; Mark Bernstein; Peter G Lawlor; Sarina R Isenberg
Journal:  BMC Palliat Care       Date:  2020-11-29       Impact factor: 3.234

6.  An ethical exploration of the narratives surrounding substance use and pain management at the end of life: a discussion paper.

Authors:  Gary Witham; Gemma Yarwood; Sam Wright; Sarah Galvani
Journal:  Nurs Ethics       Date:  2019-09-16       Impact factor: 2.874

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.